| Dependent variable | |||||||
---|---|---|---|---|---|---|---|---|
Days used | Penn total | SD work | SD social life | SD family | CGI | HAM-A | HAM-D | |
Time period (reference: baseline; type III SS p-value) | 0.029 | < 0.001 | 0.023 | < 0.001 | < 0.001 | 0.002 | 0.001 | < 0.001 |
 6 week follow-up | − 2.133** (0.830) | − 5.067*** (1.523) | − 1.367* (0.751) | − 2.233*** (0.755) | − 1.933*** (0.697) | − 0.567* (0.312) | − 2.533* (1.412) | − 1.267 (0.952) |
  3 month follow-up | − 1.667** (0.830) | − 9.367*** (1.523) | − 2.067*** (0.751) | − 4.133*** (0.755) | − 3.900*** (0.697) | − 1.133*** (0.312) | − 5.633*** (1.412) | − 4.100*** (0.952) |
Treatment group (reference: control; type III SS p-value) | 0.343 | 0.347 | 0.233 | 0.791 | 0.474 | 0.915 | 0.319 | 0.899 |
  Intervention | 1.104 (1.155) | − 2.020 (2.131) | 1.129 (0.937) | −  0.242 (0.909) | − 0.645 (0.894) | 0.041 (0.387) | − 2.302 (2.458) | 0.230 (1.575) |
Age at baseline (type III SS p-value) | 0.337 | 0.279 | 0.106 | 0.072 | 0.156 | 0.093 | 0.497 | 0.499 |
 | − 0.070 (0.072) | − 0.145 (0.133) | − 0.089 (0.054) | − 0.094* (0.051) | − 0.076 (0.053) | − 0.038* (0.022) | 0.087 (0.167) | 0.052 (0.105) |
CGI-severity at baseline (type III SS p-value) | 0.197 | 0.185 | 0.826 | 0.449 | 0.466 | N/A | 0.006 | 0.002 |
 | 0.660 (0.505) | − 1.391 (1.037) | − 0.094 (0.424) | 0.305 (0.400) | 0.303 (0.413) |  | 3.489*** (1.225) | 2.435*** (0.760) |
Number of days in past 2 weeks using meth at baseline (type III SS p-value) | N/A | 0.651 | 0.191 | 0.774 | 0.992 | 0.013 | 0.381 | 0.496 |
 |  | 0.107 (0.236) | 0.128 (0.097) | − 0.026 (0.091) | − 0.001 (0.094) | 0.091** (0.036) | 0.602** (0.265) | 0.129 (0.167) |
Time period by treatment group interaction (reference: baseline control; type III SS p-value) | 0.013 | 0.169 | 0.786 | 0.386 | 0.672 | 0.283 | 0.312 | 0.529 |
 6 week follow-up Intervention | − 2.767** (1.173) | 0.667 (2.154) | − 0.433 (1.063) | − 0.567 (1.068) | − 0.300 (0.985) | − 0.667 (0.442) | − 2.300 (1.997) | − 1.433 (1.346) |
 3 month follow-up Intervention | − 3.267*** (1.173) | 3.833* (2.154) | − 0.733 (1.063) | 0.900 (1.068) | 0.567 (0.985) | − 0.533 (0.442) | − 2.900 (1.997) | − 0.267 (1.346) |
Constant | 7.336** (3.618) | 33.193*** (6.648) | 8.201*** (2.730) | 9.324*** (2.580) | 9.194*** (2.655) | 5.526*** (0.812) | 12.418** (5.975) | 9.780** (3.774) |
Observations | 180 | 180 | 180 | 180 | 180 | 180 | 180 | 180 |
Log Likelihood | − 499.304 | − 603.844 | − 472.698 | − 470.088 | − 462.489 | − 321.576 | − 609.198 | − 537.667 |
Akaike Inf. Crit. | 1,018.608 | 1,229.687 | 967.396 | 962.175 | 946.978 | 663.153 | 1,238.396 | 1,095.333 |
Bayesian Inf. Crit. | 1050.083 | 1264.245 | 1001.955 | 996.734 | 981.537 | 694.628 | 1269.870 | 1126.808 |